| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA691218 | F | Anti-HRV activity against HRV serotype 16 | rhinovirus A16 | 3 | ALA1144873 | organism-based format | Scientific Literature | |
| 2. | ALA871997 | F | Broad spectrum antiviral activity was evaluated against HRV-16 | rhinovirus A16 | 1 | ALA1145116 | organism-based format | Scientific Literature | |
| 3. | ALA950022 | F | Antiviral activity against HRV16 in HeLa cells | rhinovirus A16 | 5 | ALA1142266 | organism-based format | Scientific Literature | |
| 4. | ALA949086 | F | Inhibition of HRV16 replication cycle progression | rhinovirus A16 | 1 | ALA1142266 | organism-based format | Scientific Literature | |
| 5. | ALA1839573 | F | Antiviral activity against Human rhinovirus 16 infected in human HeLa Ohio cells assessed as inhibition of virus-induced cytopathic effect by CellTiter-Glo assay | rhinovirus A16 | 18 | ALA1833869 | organism-based format | Scientific Literature | |
| 6. | ALA2399046 | F | Antiviral activity against Human rhinovirus A16 assessed as inhibition of viral RNA replication by luciferase reporter replicon assay | rhinovirus A16 | 4 | ALA2396517 | organism-based format | Scientific Literature | |
| 7. | ALA2399180 | F | Antiviral activity against Human rhinovirus 16 assessed as protection against virus-induced cytopathic effect by cell-based assay | rhinovirus A16 | 15 | ALA2396517 | organism-based format | Scientific Literature | |
| 8. | ALA3816981 | F | Antiviral activity against human rhinovirus 16 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | rhinovirus A16 | 9 | ALA3813594 | organism-based format | Scientific Literature | |
| 9. | ALA3816135 | F | Antiviral activity against human rhinovirus 16 assessed as reduction in viral infection in human HeLa H1 cells after 2 to 5 days by XTT reduction assay | rhinovirus A16 | 1 | ALA3813594 | organism-based format | Scientific Literature | |
| 10. | ALA4012805 | F | Antiviral activity against Human rhinovirus A16 infected in human H1HeLa cells assessed as protection against virus induced cytopathic effect after 3 days by MTT assay | rhinovirus A16 | 3 | ALA4011621 | cell-based format | Scientific Literature | |
| 11. | ALA4012809 | F | Antiviral activity against Human rhinovirus A16 infected in H1HeLa cells assessed as decrease in viral dsRNA at 6 times EC50 treated 1 hr prior to infection by DAPI staining based immunofluorescence assay | rhinovirus A16 | 2 | ALA4011621 | cell-based format | Scientific Literature | |
| 12. | ALA4012810 | F | Antiviral activity against Human rhinovirus A16 infected in H1HeLa cells assessed as decrease in viral dsRNA at 6 times EC50 treated simultaneously with infection by DAPI staining based immunofluorescence assay | rhinovirus A16 | 2 | ALA4011621 | cell-based format | Scientific Literature | |
| 13. | ALA4012811 | F | Antiviral activity against Human rhinovirus A16 infected in H1HeLa cells assessed as decrease in viral dsRNA at 6 times EC50 treated every 1 hr for 9 hrs after infection by DAPI staining based immunofluorescence assay | rhinovirus A16 | 1 | ALA4011621 | cell-based format | Scientific Literature | |
| 14. | ALA4703766 | F | Antiviral activity against Human rhinovirus 16 infected in human H1-HeLa cells assessed as reduction in virus-induced cytopathogenicity incubated for 2 to 5 days by XTT dye based analysis | rhinovirus A16 | 1 | ALA4699574 | organism-based format | Scientific Literature | |
| 15. | ALA5146834 | F | Antiviral activity against Human rhinovirus 16 infected in human H1-HeLa cells assessed as reduction in virus induced cytopathic effect incubated for 3 days by MTT assay | rhinovirus A16 | 2 | ALA5143628 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!